- SEK3.99bn
- SEK3.72bn
- SEK627.69m
Brief: Probi Q4 operating profit up at SEK 43.6 million
Brief: Probi Q4 preliminary net sales up by SEK 158 million
Brief: Probi raises SEK 602 in rights issue proceeds
Brief: Probi Q3 operating profit up at SEK 30.7 million
Brief: Probi decides on rights issue and announces terms
Brief: Probi Q2 operating profit up at SEK 20.7 million
Brief: Probi to buy Nutraceutix and expand into North American market
Brief: Probi signs new agreements in Functional Food and Consumer Healthcare
Brief: Probi Q1 operating profit increases to SEK 35.3 million
Brief: Probi signs extensive primary care distribution agreement with Ipsen
Brief: Probi and Ipsen sign extensive primary care distribution agreement
Symrise says seeking growth rather than pushing margins
Brief: Probi announces changed dividend policy effective 2016 financial year
Brief: Probi acquires license for new probiotic strains
Brief: Formpipe Software: Probi selects Sigma and Formpipe Life Science
Brief: Probi Q4 operating profit down at SEK 3.7 mln
Brief: Probi: new product format for Probi Digestis targeting kids segment
Brief: Probi launches new probiotic iron absorption product
Brief: Probi Q3 operating profit up at SEK 16.3 million